# A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults

> **NCT04956575** · PHASE1,PHASE2 · COMPLETED · sponsor: **ModernaTX, Inc.** · enrollment: 885 (actual)

## Conditions studied

- Seasonal Influenza

## Interventions

- **BIOLOGICAL:** mRNA-1010
- **BIOLOGICAL:** Placebo
- **BIOLOGICAL:** Active Comparator

## Key facts

- **NCT ID:** NCT04956575
- **Lead sponsor:** ModernaTX, Inc.
- **Sponsor class:** INDUSTRY
- **Phase:** PHASE1,PHASE2
- **Study type:** INTERVENTIONAL
- **Status:** COMPLETED
- **Start date:** 2021-07-06
- **Primary completion:** 2022-09-27
- **Final completion:** 2022-09-27
- **Target enrollment:** 885 (ACTUAL)
- **Last updated:** 2023-10-27


## Primary source

ClinicalTrials.gov registry: https://clinicaltrials.gov/study/NCT04956575

## Citation

> US National Library of Medicine, ClinicalTrials.gov registration NCT04956575, "A Study of mRNA-1010 Seasonal Influenza Vaccine in Healthy Adults". Retrieved via AI Analytics 2026-06-08 from https://api.ai-analytics.org/clinical/NCT04956575. Licensed CC0.

---

*[Clinical trials dataset](/datasets/clinical-trials) · CC0 1.0*